Evidence map›Paper›PMID 25690651›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

The atypical N-glycosylation motif, Asn-Cys-Cys, in human GPR109A is required for normal cell surface expression and intracellular signaling.

Daisuke Yasuda, Yuki Imura, Satoshi Ishii, Takao Shimizu, Motonao Nakamura

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Daisuke Yasuda*Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan; Department of Immunology, Faculty of Medicine, Akita University, Akita, Japan; Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan; and Department of Life Science, Faculty of Science, Okayama University of Science, Okayama, Japan.
Yuki Imura*Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan; Department of Immunology, Faculty of Medicine, Akita University, Akita, Japan; Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan; and Department of Life Science, Faculty of Science, Okayama University of Science, Okayama, Japan.
Satoshi Ishii*Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan; Department of Immunology, Faculty of Medicine, Akita University, Akita, Japan; Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan; and Department of Life Science, Faculty of Science, Okayama University of Science, Okayama, Japan.
Takao Shimizu*Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan; Department of Immunology, Faculty of Medicine, Akita University, Akita, Japan; Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan; and Department of Life Science, Faculty of Science, Okayama University of Science, Okayama, Japan.
Motonao Nakamura*Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan; Department of Immunology, Faculty of Medicine, Akita University, Akita, Japan; Department of Lipid Signaling, National Center for Global Health and Medicine, Tokyo, Japan; and Department of Life Science, Faculty of Science, Okayama University of Science, Okayama, Japan moto-nakamura@dls.ous.ac.jp.
Akita University · JPNational Center for Global Health and Medicine · JPOkayama University of Science · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asparagine-linked glycosylation (N-glycosylation) is necessary for the proper folding of secreted and membrane proteins, including GPCRs. Thus, many GPCRs possess the N-glycosylation motif Asn-X-Ser/Thr at their N-termini and/or extracellular loops. We found that human GPR109A (hGPR109A) has an N-glycosylation site at Asn(17) in the N-terminal atypical motif, Asn(17)-Cys(18)-Cys(19). Why does hGPR109A require the atypical motif, rather than the typical sequence? Here we show that Asn(17)-Cys(18)-Cys(19) sequence of hGPR109A possesses 2 biologic roles. First, Asn(17)-X-Cys(19) contributed to hGPR109A N-glycosylation by acting as an atypical motif. This modification is required for the normal surface expression of hGPR109A, as evidenced by the reduced surface expression of the nonglycosylated mutants, hGPR109A/N17A, and the finding that hGPR109A/C19S and hGPR109A/C19T, which are N-glycosylated at Asn(17), exhibited expression similar to the wild-type receptor. Second, the X-Cys(18)-Cys(19) dicysteine is indispensable for hGPR109A function. Substitution of Cys(18) or Cys(19) residue to Ala impaired Gi-mediated signaling via hGPR109A. We propose the disulfide bond formations of these residues with other Cys existed in the extracellular loops for the proper folding. Together, these results suggest that the atypical motif Asn(17)-Cys(18)-Cys(19) is crucial for the normal surface trafficking and function of hGPR109A.

Indexed as

Gene ExpressionAmino Acid MotifsAmino Acid SequenceAnimalsAsparagineBlotting, WesternCell Line, TumorCell MembraneCHO CellsCricetinaeCricetulusDipeptidesGlycosylationHEK293 CellsHeLa CellsHexosyltransferasesAsparaginecysteinylcysteineDipeptidesHCAR2 protein, humanHexosyltransferasesMembrane ProteinsReceptors, G-Protein-CoupledReceptors, NicotinicSTT3A protein, humanSTT3B protein, humanAsn-X-Cys motifNicotinic acid receptorN-linked glycosylationreceptor activationSTT3B

Identifiers

PMID25690651
PMCPMC4447229
OpenAlexW2083801055

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.